Orange Book product · Generic (ANDA)
CEFTAZIDIME
CEFTAZIDIME
At a glance
Nov 20, 1985
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 20, 1985
41 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFTAZIDIME
Strength
2GM/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 062640
Product number
003
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of CEFTAZIDIME
- 2011CEFTAZIDIME IN DEXTROSE CONTAINERBrand (NDA)
NDA 050823 · B BRAUN
- 1990CEPTAZBrand (NDA)
NDA 050646 · GLAXOSMITHKLINE
- 1985FORTAZBrand (NDA)
NDA 050578 · PAI HOLDINGS PHARM
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065481 · AUROBINDO PHARMA LTD
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065482 · AUROBINDO PHARMA LTD
- 2008CEFTAZIDIMEGeneric (ANDA)
ANDA 065196 · WOCKHARDT
- 1995PENTACEFGeneric (ANDA)
ANDA 063322 · GLAXOSMITHKLINE
- 1993TAZICEFGeneric (ANDA)
ANDA 064032 · HOSPIRA
- 1992PENTACEFGeneric (ANDA)
ANDA 064006 · GLAXOSMITHKLINE
- 1992PENTACEFGeneric (ANDA)
ANDA 064008 · GLAXOSMITHKLINE
- 1986TAZIDIME IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062739 · LILLY
- 1986TAZICEFGeneric (ANDA)
ANDA 062662 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
